Form 4/A for ABBV AbbVie
Accepted 2022-05-20 00:00:00 ET · period of report 2022-05-16 · accession 0001179110-22-003108 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2022-05-20 | 2022-05-16 | ABBV | Gosebruch Henry O | EVP, Chief Strategy Off | S - Sale+OE | $155.00 | -84.0K | 41.6K | -67% | -$13.01M |
| DA | 2022-05-20 | 2022-05-16 | ABBV | Gosebruch Henry O | EVP, Chief Strategy Off | M - OptEx | $54.86 | +84.0K | 125.6K | +202% | +$4.61M |
| DA | 2022-05-20 | 2022-05-16 | ABBV | Gosebruch Henry O | EVP, Chief Strategy Off | M - OptEx | $54.86 | -84.0K | 0 | -100% | -$4.61M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2022-05-16 | S | D | 83,960 | $155.00 | 41,623 | D | — | — | |
| 2 | Common | Common Stock, $0.01 par value | 2022-05-16 | M | A | 83,960 | $54.86 | 125,583 | D | — | — | |
| 3 | Derivative | Option (Right to Buy) | 2022-05-16 | M | D | 83,960 | $54.86 | 0 | D | $54.86 · 2017-02-18 to 2026-02-17 | 83,960 Common Stock | (F3) Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |